BioSpace News Archive

Malin Corporation plc (ISE:MLC), a company investing in highly innovative life sciences companies, today notes that its investee company Poseida Therapeutics, Inc. (“Poseida”), a clinical-stage biotechnology company based in San Diego, California, has filed a registration statement on Form S-1 (“Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering (“IPO”) in the United States of shares of Poseida’s common stock

Non-Invasive Surgical Robotics Company with “Pure Sci-Fi” Technology Joins The Observer’s List of Top Firms

Medidata today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team.

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries.

Rowley Law PLLC is investigating potential claims against Loxo Oncology, Inc. and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Eli Lilly and Company

Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation (hereinafter “Shimadzu”), in order to further expand its Healthcare Business in North America, has acquired CORE Medical Imaging, Inc. (hereinafter “CMI”).

Digital technologies create new opportunities to transform health care and empower patients to make better informed decisions about their health

Rite Aid Corporation (NYSE: RAD) announced today that John Standley, chief executive officer; Kermit Crawford, president and chief operating officer; and Darren Karst, senior executive vice president, chief financial officer and chief administrative officer, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, at the Westin St. Francis Hotel in San Francisco. Rite Aid’s presentation is scheduled for 7:30 a.m. PT.

LimaCorporate (Lima) and the top-ranked orthopedic hospital in the U.S., Hospital for Special Surgery (HSS) announced today they are founding the first additive manufacturing 3D printing facility for custom complex implants in a hospital setting.

New materials raise awareness on dangers of opioids and reinforce guidelines for pain management